An Update from Our Firm about COVID-19

Abraham, Watkins, Nichols, Sorrels, Agosto, Aziz & Stogner remains fully operational and committed to serving our clients and colleagues throughout the Coronavirus (COVID-19) crisis. As we follow the CDC guidelines and practice social distancing, we remain available for phone consultations and remote meetings with both current and prospective clients and colleagues. Please contact our office by email or by calling 713-222-7211 with any questions. We look forward to hearing from you.

Posts tagged "FDA"

FDA Recalls RegenErect

On February 24, 2012 the Food and Drug Administration (FDA) announced a nationwide recall of RegenErect, which was produced by Regeneca, Inc., previously known at Ethos Environmental, Inc. This product was marketed as a male enhancement pill. According to the company, RegenErect contains Tadalafil, which is an approved drug to treat male Erectile Dysfunction (ED). Unlike Tadalafil, RegenErect has been distributed over the internet and given as samples at public events in the United States and in Puerto Rico.

FDA Issues Warning Regarding Transvaginal Mesh

According to a recent Food and Drug Administration (FDA) warning, transvaginal placement of surgical mesh might not be the best treatment option in patients suffering from pelvic organ prolapse (POP) or stress urinary incontinence (SUI). Transvaginal mesh is a type of surgical mesh that is permanently implanted in patients suffering from POP or SUI to strengthen the weakened vaginal wall. Although doctors routinely use transvaginal mesh to treat such conditions, the FDA warns that thousands of women are at risk of developing serious health complications despite the fact that much safer and similarly effective alternatives exist.

FDA Issues Warning About Use of Mesh In Certain Surgical Procedures

Women who have undergone certain surgical procedures involving the placement of surgical mesh are being warned by the Food and Drug Administration that the added risk associated with the surgical mesh may outweigh the intended benefit. Earlier this month, the FDA released an updated safety bulletin warning health care providers and patients that this product (commonly used in surgery to treat pelvic prolapse) may increase the risk of pain, bleeding and infection in women - as compared to women who have traditional surgery with stitches.

  • $50+ Million Personal Injury Fire and Explosion

    The firm successfully represented nearly 100 victims who suffered personal injuries and damages to property from a large fire and explosion resulting in a settlement of more than $50 million. The firm served as lead lawyers on the steering committee in this litigation.

  • $80 Million Personal Injury Large Plant Explosion

    The firm successfully represented 270 plaintiffs, taking a lead role in the plaintiffs’ steering committee, who suffered injuries in a large plant explosion resulting in a settlement of nearly $80 million.

  • $50+ Million Personal Injury Plant Fire and Explosion

    The firm successfully represented 45 personal injury victims in a plant fire and explosion, serving on the plaintiffs steering committee, concluding with a settlement of more than $50 million.

  • $22+ Million Personal Injury Work Site Accident

    The firm prevailed in a personal injury trial for a worksite injury client with the jury returning a verdict and resulting in a judgment of over $22 million for the firm’s client.

  • $12 Million Auto Accident 18-Wheeler Collision

    The firm successfully achieved a $12 million settlement for the family of a man who died in an 18 wheeler collision.

  • $30 Million Personal Injury Burn Victims

    The firm prevailed on behalf of three burn victims with settlements totaling nearly $30 million.

Our Record Of Success

When you are hurt and you choose a law firm to represent you in court or at the negotiation table, you need to carefully consider the firm's record.

Read More Success Stories

Let Us Help You Request a Free Consultation Today

Get Help Now

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Back to top